{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:32:23Z","timestamp":1779114743171,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.vaccine.2013.08.086","type":"journal-article","created":{"date-parts":[[2013,9,8]],"date-time":"2013-09-08T06:47:34Z","timestamp":1378622854000},"page":"5009-5014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity"],"prefix":"10.1016","volume":"31","author":[{"given":"Phillip R.","family":"Pittman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Schmader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio G.","family":"Barrera-Oro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.086_bib0005","unstructured":"Anthrax vaccine adsorbed. Lansing, Michigan department of Public Health, 1978.[package insert]."},{"key":"10.1016\/j.vaccine.2013.08.086_bib0010","series-title":"Current clinical topics in infectious diseases","first-page":"335","article-title":"Anthrax: clinical features, pathogenesis and potential biological warfare threat","author":"Friedlander","year":"2000"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0015","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0025","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0030","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.287.7.863","article-title":"Fatal inhalational anthrax in a 94 year old Connecticut woman","volume":"287","author":"Barakat","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4172\/2157-2526.1000107","article-title":"Anthrax bioterrorism: prevention, diagnosis and management strategies","volume":"2","author":"Fowler","year":"2011","journal-title":"J Bioterr Biodef"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0040","first-page":"125","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys","volume":"Suppl. 87","author":"Ivins","year":"1995","journal-title":"Salisbury Med J"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0050","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0055","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am J Pub Health"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0070","unstructured":"Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Medical Follow-up Agency. The Anthrax Vaccine. Is it Safe? Does It Work? Washington, DC: National Academy Press; Institute of Medicine, 2002."},{"key":"10.1016\/j.vaccine.2013.08.086_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0264-410X(00)00174-2","article-title":"Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans","volume":"19","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2013.08.086_bib0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0085","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months, a randomized trial","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0090","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0264-410X(02)00058-0","article-title":"Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen","volume":"8","author":"Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0105","article-title":"Biologics license application supplement approval letter","volume":"December 11","author":"Sun","year":"2008","journal-title":"Food and drug administration"},{"key":"10.1016\/j.vaccine.2013.08.086_bib0110","unstructured":"Emergent BioSolutions, 2012. BioThrax\u00ae (Anthrax Vaccine Adsorbed), [package insert. http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/UCM074923.pdf]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T04:27:40Z","timestamp":1539404860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":22,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0264410X13011985"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}